Patent ID: 11946040
Assignee: THE GENERAL HOSPITAL CORPORATION
Field: Biotechnology (Chemistry)
Classification: CPC C | IPC C

Claim 2:
3. The ABE variant of claim 2, wherein the at least one of the one or more E. coli TadA monomers comprise mutations at amino acid residue positions that correspond to amino acid residues:
R13A;
20A and 21A;
21A, and 23A;
26A;
49A;
74A;
77A;
82G;
11A;
109W;
111A;
139A and 140A;
143G;
153A;
58G;
72A;
128A and 129A;
139A and 140A;
148A; or
150A
of the amino acid sequence of SEQ ID NO: 1 or the amino acid sequence of SEQ ID NO: 34.